News
Legalizing Recreational Marijuana in Colorado Reversed a 14-Year Trend of Rising Opioid-Related Deaths
The marijuana industry is, for lack of a better pun, sprouting like a weed. According to cannabis research firm ArcView, the North American legal weed market grew by 34% in 2016 and is expected to....
Better Buy: Exelixis, Inc. vs. Intra-Cellular Therapies Inc.
Biotech investors are always looking for the next big thing. That's exactly what they found in Exelixis (NASDAQ: EXEL), which ranked as one of the top biotech stocks of 2016 (and 2015 also). But....
3 Stocks That Turned $3,000 Into $7,300 or More So Far in 2017
If you have just $3,000 to invest, that's a good foundation upon which to start building your portfolio. But resist the urge to bet it all on just one stock. Diversifying your holdings, even when....
3 Healthcare Stocks That Soared This Week: Are They Buys?
It's stunning just how much healthcare stocks can move in only a matter of five days. For three healthcare stocks, the past week was especially fantastic thanks to major catalysts.TransEnterix....
With Lots of Moving Pieces, Intuitive Surgical, Inc. Reports Yet Another Strong Quarter
Intuitive Surgical (NASDAQ: ISRG) shareholders like myself have gotten spoiled. After some lean years following the onset of the Affordable Care Act and the concurrent tightening of hospitals'....
With Lots of Moving Pieces, Intuitive Surgical, Inc. Reports Yet Another Strong Quarter
Intuitive Surgical (NASDAQ: ISRG) shareholders like myself have gotten spoiled. After some lean years following the onset of the Affordable Care Act and the concurrent tightening of hospitals'....
With Lots of Moving Pieces, Intuitive Surgical, Inc. Reports Yet Another Strong Quarter
Intuitive Surgical (NASDAQ: ISRG) shareholders like myself have gotten spoiled. After some lean years following the onset of the Affordable Care Act and the concurrent tightening of hospitals'....
Intuitive Surgical Continues Its Strong Growth
Intuitive Surgical, Inc. (NASDAQ: ISRG), the leader in robotic-assisted surgery, announced the results of its just-completed third quarter after the market closed on Thursday. The company reported....
Intuitive Surgical Continues Its Strong Growth
Intuitive Surgical, Inc. (NASDAQ: ISRG), the leader in robotic-assisted surgery, announced the results of its just-completed third quarter after the market closed on Thursday. The company reported....
Intuitive Surgical Continues Its Strong Growth
Intuitive Surgical, Inc. (NASDAQ: ISRG), the leader in robotic-assisted surgery, announced the results of its just-completed third quarter after the market closed on Thursday. The company reported....
How Big of a Deal Is Celgene's Flop?
Celgene (NASDAQ: CELG) shuttered two GED-301 Crohn's disease trials this week after an interim look at data by independent monitors proved disappointing. The late-stage failure dings Celgene's....
Why uniQure N.V. Stock Is Hopping Today
Shares of the gene therapy company uniQure N.V. (NASDAQ: QURE) rose by as much as 27% in early-morning trading today on over 27 times the average volume. uniQure's stock is responding positively....
Why Celgene Corporation Dropped Today
Celgene (NASDAQ: CELG) is down 10.2% at 12:09 p.m. Friday after announcing yesterday after the market closed that it was stopping a clinical trial testing GED-0301 (mongersen) in Crohn's disease....
3 High-Yield Pharmaceutical Stocks
Pharmaceutical stocks are generally an outstanding place to look for sustainable sources of passive income. Even though most companies offer fairly modest yields due to the costly nature of....
3 High-Yield Pharmaceutical Stocks
Pharmaceutical stocks are generally an outstanding place to look for sustainable sources of passive income. Even though most companies offer fairly modest yields due to the costly nature of....
Why Marijuana Stocks Won't Pay a Dividend, Even if They're Profitable
There aren't too many industries that can grow at 20%-plus a year over the next five years, but marijuana could be one of them. Cannabis research firm ArcView believes the legal North American pot....
Celgene Could Be the Best CAR-T Stock to Buy, Not Gilead Sciences
Gilead Sciences' (NASDAQ: GILD) recently approved Yescarta could be a billion-dollar blockbuster cancer-cell therapy, but the company could face stiff competition from Celgene (NASDAQ:....
Celgene Could Be the Best CAR-T Stock to Buy, Not Gilead Sciences
Gilead Sciences' (NASDAQ: GILD) recently approved Yescarta could be a billion-dollar blockbuster cancer-cell therapy, but the company could face stiff competition from Celgene (NASDAQ:....
Celgene Could Be the Best CAR-T Stock to Buy, Not Gilead Sciences
Gilead Sciences' (NASDAQ: GILD) recently approved Yescarta could be a billion-dollar blockbuster cancer-cell therapy, but the company could face stiff competition from Celgene (NASDAQ:....
Why Agenus Inc. Stock Slumped Today
Shares of the cancer immunotherapy and vaccine company Agenus (NASDAQ: AGEN) fell by as much as 16.7% on nearly five times the average volume today, before ultimately ending the day down by only....
Why TransEnterix Stock Tanked Today
Shares of TransEnterix (NYSEMKT: TRXC), an early commercial-stage robotic surgery company, ended today's trading session down another 16.4%. The company's shares have now given back a healthy....
Why TransEnterix Stock Tanked Today
Shares of TransEnterix (NYSEMKT: TRXC), an early commercial-stage robotic surgery company, ended today's trading session down another 16.4%. The company's shares have now given back a healthy....
Why TransEnterix Stock Tanked Today
Shares of TransEnterix (NYSEMKT: TRXC), an early commercial-stage robotic surgery company, ended today's trading session down another 16.4%. The company's shares have now given back a healthy....
Abbott Laboratories Q3 2017 Earnings Conference Call Transcript (ABT)
Abbott Laboratories (NYSE: ABT)Image source: The Motley Fool.Q3 2017 Earnings Conference CallOct. 18, 2017, 9:00 a.m. ET Continue readingSource: Fool.com
BOIRON : Activity in the third quarter of 2017
ACTIVITY IN THE THIRD QUARTER OF 2017
(Unaudited data)
CUMULATIVE ACTIVITY AS OF THE END OF SEPTEMBER 2017
in thousands of euros
2016
2017
Variation
at current exchange....
